HomeBIOV • CNSX
add
Biovaxys Technology Corp
Previous close
$0.040
Day range
$0.038 - $0.040
Year range
$0.035 - $0.080
Market cap
11.71M CAD
Avg Volume
166.45K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.14M | 231.14% |
Net income | -1.07M | -306.58% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 157.42K | -83.69% |
Total assets | 1.28M | -13.19% |
Total liabilities | 3.02M | 5.22% |
Total equity | -1.74M | — |
Shares outstanding | 291.53M | — |
Price to book | -4.00 | — |
Return on assets | -220.24% | — |
Return on capital | 161.23% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -1.07M | -306.58% |
Cash from operations | -892.64K | -37,574.60% |
Cash from investing | — | — |
Cash from financing | 847.07K | -12.01% |
Net change in cash | -54.39K | -105.64% |
Free cash flow | -871.05K | 33.00% |
About
Headquarters
Website
